Beyond Beer Taking Big Swigs from Big Beer's Bottle

Jan. 29, 2025 - 3 minutes 30 seconds
Close-up of the metal tops of a case of beer cans.

Overview:

  • We estimate the "beyond beer" category (i.e., flavored alcohol in a can) is US$22 billion in sales and 20% the size of beer, up from 6% a decade ago.
  • Still, it represents only 6% of the sales of the big three U.S. brewers, which have struggled with beyond beer's high degree of market fragmentation, consumer churn and failure rate.
  • Given beyond beer's rising importance to consumers, we think the brewers will need to increase their involvement going forward.
  • We forecast that beyond beer will reach 32% of beer sales by 2030, assuming a 7% CAGR. This represents a 40 bp annual headwind to beer sales.

The TD Cowen Insight

The beyond beer category has grown to US$22 billion in sales over the past decade and has significantly cannibalized beer sales. The big U.S. brewers have struggled to penetrate the space due to its high degree of fragmentation and high churn. However, we think they need to figure out how to succeed here to offset the structural pressures on their core beer businesses.

Younger Generations Driving Growth of Beyond Beer Category

We estimate that the beyond beer category has grown to US$22 billion in sales, which makes it 20% the size of beer compared to only 6% a decade ago. Our research indicates that it has contributed to structural declines in conventional beer by catering to younger consumers seeking sweeter, more adventurous flavor combinations as they enter legal drinking age. This younger generation has grown up with more flavor variety across food and beverages than past generations, so it makes sense to assume that they will seek great-tasting flavor in alcohol drinks as well.

While beyond beer may look like a compelling opportunity for expansion for the big U.S. brewers, they have had a difficult time capitalizing on it in a material way. The category is highly fragmented with low barriers to entry, high consumer churn and high failure rates. Creating an authentic new-to-world brand in a grassroots manner requires a lot of patience, which the big public companies don't typically have. In fact, beyond beer represents only 6% of the sales of the big three U.S. brewers today. Given its rising importance to consumers, we think the brewers will need to increase their involvement going forward.

Success will require a more patient approach to innovation and a careful assessment of which acquisition targets will stand the test of time.

Our Survey Suggests Beyond Beers a Threat to Big Brewers

We surveyed a group of beer and beyond beer executives and used our proprietary and government survey data from 150,000+ respondents to dig deeper into the dynamics of the beyond beer category. The findings support our view that this category represents a significant threat to the big brewers' business models.

Financial and Industry Model Implications

Based on our consumer surveys, we estimate that beyond beer will grow at a 7% rate over the next six years and reach 32% of beer sales by 2030. We estimate that beyond beer's growth will pose a 0.4% annual headwind to consumer spending on beer. This assumes that 50% of beyond beer's volume comes at the expense of beer drinking occasions, and that the higher price points cannibalize the disposable income that consumers would have spent on beer.

What to Watch

We would not be surprised to see increased consolidation in this category in the year ahead. The race to the shelf has led to an influx of start-up brands, many of which are low quality and a confusing shopping experience for consumers. We expect retailers to discontinue underperforming brands and larger alcohol companies to acquire the few that have gained traction. We expect spirits-based RTDs (ready-to-drink) to fare better than their malt-based counterparts because they are growing faster, are more premium and offer higher gross profit per case versus traditional beer.

Subscribing clients can read the full report, 30th Annual Survey: Positive Outlook For Drug Prices – Ahead Of The Curve, on the TD One Portal

The views or opinions expressed herein represent the personal views of the writer and do not necessarily reflect the views of TD Securities or its affiliates.

This material is intended to provide commentary on the market for commodities discussed herein.

Not Advice: The information contained in this material is for informational purposes only and is not intended to provide professional, investment or any other type of advice or recommendation, or to create a fiduciary relationship. Neither TD Securities (USA) LLC (“TD Securities USA”) nor any of its affiliates (collectively, “TD”) makes any representation or warranty, express or implied, regarding the accuracy, reliability, completeness, appropriateness or sufficiency for any purpose of any information included in this material. Certain information may have been provided by third-party sources and, while believed to be reliable, has not been independently verified by TD, and its accuracy or completeness acannot be guaranteed. You should not make an investment decision in reliance on this material, which is intended to provide only brief comments on the topics addressed, and is based on information that is likely to change without notice.

Not Securities or Derivatives Research: This material has not been produced, reviewed or approved by TD’s securities or derivatives research departments. The views of the author may differ from others at TD, including TD securities or derivatives research analysts.

Not Independent: The views expressed in this material may not be independent of the interests of TD. TD may engage in conflicting activities, including principal trading before or after posting this material, or other services involving commodities discussed in this material, or related financial products. TD may have a financial interest in the commodities discussed in this material, including, without limitation, a financial product that references such commodities.

Not An Offer or Solicitation: Nothing contained in this material is, or should be construed as, an offer, a solicitation of an offer or an invitation to buy or sell any commodity, or any financial product that references such commodity, and it is not intended for distribution in any jurisdiction where such distribution would be contrary to law.

Risk of Loss. Transactions in commodities, and financial instruments that reference commodities, involve risk of loss, and are subject to the risks of fluctuating prices. You should weigh potential benefits against the risks. Past performance is no indicator of future performance and the Materials are not intended to forecast or predict future events.


Portrait of Robert Moskow

Managing Director, Consumer – Food & Beverages Research Analyst, TD Cowen

Portrait of Robert Moskow


Managing Director, Consumer – Food & Beverages Research Analyst, TD Cowen

Portrait of Robert Moskow


Managing Director, Consumer – Food & Beverages Research Analyst, TD Cowen

Rob Moskow is an II-ranked analyst covering food and beverages. Prior to joining TD Cowen, Robert spent 21 years at Credit Suisse and four years on the board of the Consumer Analyst Group of New York (CAGNY). He holds a BA in English from Tufts University and an MBA in Marketing from the J.L. Kellogg Graduate School at Northwestern University.